Two Drugs For Heart Failure Show Mixed Results; Novartis Pharmaceuticals Corporation (NVS)'s Diovan Should Be Used More Often And Scios Inc. (JNJ)'s Natrecor Should Not Be Used At All, VA Medical Center And Baylor University Research Shows
5/22/2008 7:36:39 AM
HealthDay -- Two new studies have produced mixed results for two different drugs that are often used to treat heart failure. In the first study, researchers found limited benefit from a drug called valsartan (Diovan), which is used to lower systolic blood pressure. The second study found no benefit from the use of a drug known as nesiritide (Natrecor) for heart failure in an outpatient setting. Both reports are published in the May 21 issue of Circulation: Heart Failure.